Anzalone Christopher Richard

CIK 00014230291 companyPASADENA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001423029

Recent Transactions

50 trades

Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2026-01-02$65.88/sh−7,416→ 3,798,510 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2026-01-02$66.39/sh−5,771→ 3,792,739 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-17$64.51/sh−35,750→ 3,834,920 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-17$66.30/sh−1,981→ 3,831,957 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-17$65.53/sh−982→ 3,833,938 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-17$63.55/sh−46,287→ 3,870,670 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16$66.77/sh−166→ 3,920,178 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16$64.96/sh−1,000→ 3,921,644 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16$65.77/sh−1,300→ 3,920,344 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16$61.25/sh−10,963→ 3,951,876 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16$62.94/sh−8,476→ 3,929,305 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16$67.87/sh−3,221→ 3,916,957 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16$60.51/sh−8,416→ 3,962,839 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16$64.29/sh−6,661→ 3,922,644 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16$62.12/sh−14,095→ 3,937,781 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-15$69.96/sh−8,147→ 3,971,255 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-15$69.28/sh−21,321→ 3,979,402 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-15$68.67/sh−100,532→ 4,000,723 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-12+180,000→ 4,101,255 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-04-11$11.49/sh−50,800→ 3,921,255 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-04-10$10.87/sh−50,000→ 3,972,055 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-04-09$9.93/sh−35,305→ 4,027,072 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-04-09$10.75/sh−3,400→ 4,023,672 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-04-09$11.76/sh−1,617→ 4,022,055 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-03-13+340,000→ 4,113,802 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-03-13$15.07/sh−51,425→ 4,062,377 total
Exercise/Conversion
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-03-04$7.75/sh+133,333→ 4,073,802 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-03-04$17.02/sh−133,333→ 3,773,802 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-03-03$18.03/sh−166,667→ 3,907,135 total
Exercise/Conversion
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-03-03$7.75/sh+166,667→ 3,940,469 total
Exercise/Conversion
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Stock Option (right to buy Common Stock)
2025-03-03−133,333→ 51,726 total
Exercise/Conversion
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Stock Option (right to buy Common Stock)
2025-03-03−166,667→ 185,059 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-02-07$20.10/sh+9,550→ 3,773,802 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-01-02$19.05/sh−11,520→ 3,764,252 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-23$19.59/sh−12,563→ 3,775,772 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-18$20.52/sh−12,653→ 3,702,394 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-18$21.74/sh−8,260→ 3,694,134 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-18+100,000→ 3,788,335 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-18$22.12/sh−5,799→ 3,688,335 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-01-31$32.71/sh−19,730→ 3,715,048 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-01-31$32.16/sh−37,769→ 3,734,778 total
Exercise/Conversion
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Stock Option (right to buy)
2024-01-31−57,499→ 351,726 total
Exercise/Conversion
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-01-31$14.54/sh+57,499→ 3,772,547 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-01-02$30.74/sh−4,634→ 3,720,366 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-01-02$31.25/sh−5,318→ 3,715,048 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-12-20$28.54/sh−12,000→ 3,725,000 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-10-25$24.21/sh−24,338→ 3,737,000 total
Exercise/Conversion
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Stock Option (right to buy)
2023-09-18+57,555→ 409,225 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-09-18$28.00/sh−31,523→ 3,787,570 total
Exercise/Conversion
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-09-18$4.75/sh+57,755→ 3,819,093 total

Companies

ARROWHEAD PHARMACEUTICALS, INC.
Director, President and CEO
$ARWR

Recent Filings

Address

201 SOUTH LAKE AVENUE SUITE 703

PASADENA, CA, 91101

View on SEC.gov